Leonard L Mazur - Net Worth and Insider Trading

Leonard L Mazur Net Worth

The estimated net worth of Leonard L Mazur is at least $7 Million dollars as of 2024-04-30. Leonard L Mazur is the Executive Chairman, 10% Owner of Citius Pharmaceuticals Inc and owns about 10,255,343 shares of Citius Pharmaceuticals Inc (CTXR) stock worth over $7 Million. Leonard L Mazur is also the Director of Tharimmune Inc and owns about 4,949 shares of Tharimmune Inc (THAR) stock worth over $1,841. Details can be seen in Leonard L Mazur's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Leonard L Mazur has not made any transactions after 2022-01-14 and currently still holds the listed stock(s).

Transaction Summary of Leonard L Mazur

To

Leonard L Mazur Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Leonard L Mazur owns 3 companies in total, including Citius Pharmaceuticals Inc (CTXR) , Gadsden Properties Inc (FCRE) , and Tharimmune Inc (THAR) .

Click here to see the complete history of Leonard L Mazur’s form 4 insider trades.

Insider Ownership Summary of Leonard L Mazur

Ticker Comapny Transaction Date Type of Owner
CTXR Citius Pharmaceuticals Inc 2023-10-10 director & 10 percent owner & Chief Executive Officer
FCRE Gadsden Properties Inc 2011-06-30 director
THAR Tharimmune Inc 2022-01-14 director

Leonard L Mazur Latest Holdings Summary

Leonard L Mazur currently owns a total of 2 stocks. Among these stocks, Leonard L Mazur owns 10,255,343 shares of Citius Pharmaceuticals Inc (CTXR) as of September 27, 2019, with a value of $7 Million and a weighting of 99.97%. Leonard L Mazur also owns 4,949 shares of Tharimmune Inc (THAR) as of January 14, 2022, with a value of $1,841 and a weighting of 0.03%.

Latest Holdings of Leonard L Mazur

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CTXR Citius Pharmaceuticals Inc 2019-09-27 10,255,343 0.72 7,334,621
THAR Tharimmune Inc 2022-01-14 4,949 0.37 1,841

Holding Weightings of Leonard L Mazur


Leonard L Mazur Form 4 Trading Tracker

According to the SEC Form 4 filings, Leonard L Mazur has made a total of 1 transactions in Citius Pharmaceuticals Inc (CTXR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Citius Pharmaceuticals Inc is the acquisition of 2,234,700 shares on September 27, 2019, which cost Leonard L Mazur around $2 Million.

According to the SEC Form 4 filings, Leonard L Mazur has made a total of 1 transactions in Tharimmune Inc (THAR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Tharimmune Inc is the acquisition of 1,000 shares on January 14, 2022, which cost Leonard L Mazur around $100,000.

Insider Trading History of Leonard L Mazur

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Leonard L Mazur Trading Performance

GuruFocus tracks the stock performance after each of Leonard L Mazur's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Leonard L Mazur is 8.39%. GuruFocus also compares Leonard L Mazur's trading performance to market benchmark return within the same time period. The performance of stocks bought by Leonard L Mazur within 3 months outperforms 4 times out of 8 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Leonard L Mazur's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Leonard L Mazur

Average Return

-44.08%

Average return per transaction

Outperforming Transactions

13%

1 out of 8 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 1.18 8.39 -21.87 -44.08 -25.82 -10.18
Relative Return to S&P 500(%) 0.47 5.9 -21.4 -46.79 -35.3 -22.88

Leonard L Mazur Ownership Network

Ownership Network List of Leonard L Mazur

No Data

Ownership Network Relation of Leonard L Mazur


Leonard L Mazur Owned Company Details

What does Citius Pharmaceuticals Inc do?

Who are the key executives at Citius Pharmaceuticals Inc?

Leonard L Mazur is the director & 10 percent owner & Chief Executive Officer of Citius Pharmaceuticals Inc. Other key executives at Citius Pharmaceuticals Inc include director & Vice Chairman Myron Z Holubiak , Chief Financial Officer Jaime Bartushak , and Chief Medical Officer Myron Czuczman .

Citius Pharmaceuticals Inc (CTXR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Citius Pharmaceuticals Inc (CTXR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Citius Pharmaceuticals Inc (CTXR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Citius Pharmaceuticals Inc (CTXR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Citius Pharmaceuticals Inc Insider Transactions

No Available Data

Leonard L Mazur Mailing Address

Above is the net worth, insider trading, and ownership report for Leonard L Mazur. You might contact Leonard L Mazur via mailing address: C/o Citius Pharmaceuticals, Inc., 11 Commerce Drive, 1st Floor, Cranford Nj 07016.

Discussions on Leonard L Mazur

No discussions yet.